Filing Details

Accession Number:
0001209191-20-004807
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-24 16:10:12
Reporting Period:
2020-01-22
Accepted Time:
2020-01-24 16:10:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1654151 Deciphera Pharmaceuticals Inc. DCPH Pharmaceutical Preparations (2834) 200299725
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1752827 C. Daniel Martin C/O Deciphera Pharmaceuticals, Inc.
200 Smith Street
Waltham MA 02451
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-01-22 26,999 $36.10 43,999 No 4 M Direct
Common Stock Disposition 2020-01-22 26,999 $67.18 17,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-01-22 26,999 $0.00 26,999 $36.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
63,001 2028-09-17 No 4 C Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. 25% of the shares vested on September 18, 2019 and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to continued service through such dates.